Program DIrector, Endocrine Tumors
Mass General Brigham Cancer Institute
Boston, MA, United States
Dr. Lori Wirth is the Elizabeth and Michael Ruane Endowed Chair of Medical Oncology, Medical Oncology Program Director of the Mass General Brigham Endocrine Tumors Program and Professor in Medicine at Harvard Medical School. Dr. Wirth received her BA from Brown University and her MD from Columbia University College of Physicians and Surgeons. She completed training at New York Presbyterian Hospital, Dana-Farber Cancer Institute and Brigham and Women’s Hospital. She was on faculty at Dana-Farber Cancer Institute prior to joining Mass General in 2008. Dr. Wirth is a leading authority in advanced thyroid cancer and head and neck oncology. Beyond Mass General, Dr. Wirth is a former Chairperson of the International Thyroid Oncology Group (ITOG), is a founding Executive Committee member of Thyroid International Recommendations Online (TIRO) and sits on a number of other national and international oncology committees, including the American Thyroid Association Thyroid Cancer Guidelines Committee, the National Comprehensive Cancer Network’s Thyroid Cancer Committee and ABIM’s Medical Oncology Examination Approval Committee.
Disclosure information not submitted.
MTP33 - Targeted Therapy in Advanced Thyroid Cancer
Monday, June 15, 2026
2:35 PM - 3:15 PM CT